

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of tolerance induction (GO:0002645) | 9.43051525 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 8.82249792 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 8.82249792 |
| 4 | kynurenine metabolic process (GO:0070189) | 8.57248088 |
| 5 | sperm capacitation (GO:0048240) | 8.41692552 |
| 6 | regulation of tolerance induction (GO:0002643) | 8.17403394 |
| 7 | antigen processing and presentation via MHC class Ib (GO:0002475) | 8.09496486 |
| 8 | regulation of clathrin-mediated endocytosis (GO:2000369) | 7.37433454 |
| 9 | antigen processing and presentation of endogenous antigen (GO:0019883) | 7.31428404 |
| 10 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 7.06831210 |
| 11 | regulation of chronic inflammatory response (GO:0002676) | 6.79089545 |
| 12 | indole-containing compound catabolic process (GO:0042436) | 6.45639821 |
| 13 | indolalkylamine catabolic process (GO:0046218) | 6.45639821 |
| 14 | tryptophan catabolic process (GO:0006569) | 6.45639821 |
| 15 | single fertilization (GO:0007338) | 6.42029150 |
| 16 | heterotypic cell-cell adhesion (GO:0034113) | 6.28887576 |
| 17 | tryptophan metabolic process (GO:0006568) | 5.52350682 |
| 18 | negative regulation of interleukin-10 production (GO:0032693) | 5.47981257 |
| 19 | positive regulation of type 2 immune response (GO:0002830) | 5.47030249 |
| 20 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 4.92014240 |
| 21 | negative regulation of endopeptidase activity (GO:0010951) | 4.87489593 |
| 22 | sulfur amino acid catabolic process (GO:0000098) | 4.78552199 |
| 23 | negative regulation of peptidase activity (GO:0010466) | 4.65860538 |
| 24 | aromatic amino acid family catabolic process (GO:0009074) | 4.56036060 |
| 25 | complement activation, alternative pathway (GO:0006957) | 4.47959261 |
| 26 | benzene-containing compound metabolic process (GO:0042537) | 4.44449924 |
| 27 | fertilization (GO:0009566) | 4.20023126 |
| 28 | regulation of acrosome reaction (GO:0060046) | 4.19025034 |
| 29 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.16792160 |
| 30 | cellular biogenic amine catabolic process (GO:0042402) | 4.09932432 |
| 31 | amine catabolic process (GO:0009310) | 4.09932432 |
| 32 | fusion of sperm to egg plasma membrane (GO:0007342) | 4.08495479 |
| 33 | indolalkylamine metabolic process (GO:0006586) | 3.98657566 |
| 34 | negative regulation of interleukin-8 production (GO:0032717) | 3.84249457 |
| 35 | negative regulation of protein autophosphorylation (GO:0031953) | 3.77690809 |
| 36 | alpha-linolenic acid metabolic process (GO:0036109) | 3.76096787 |
| 37 | valine metabolic process (GO:0006573) | 3.64081464 |
| 38 | response to misfolded protein (GO:0051788) | 3.63835468 |
| 39 | low-density lipoprotein particle clearance (GO:0034383) | 3.56248494 |
| 40 | negative regulation of T cell apoptotic process (GO:0070233) | 3.46914874 |
| 41 | phospholipid homeostasis (GO:0055091) | 3.46576814 |
| 42 | epithelial cell morphogenesis (GO:0003382) | 3.42734080 |
| 43 | aromatic amino acid family metabolic process (GO:0009072) | 3.42333922 |
| 44 | digestion (GO:0007586) | 3.38513070 |
| 45 | positive regulation of antigen processing and presentation (GO:0002579) | 3.37185349 |
| 46 | reverse cholesterol transport (GO:0043691) | 3.29869728 |
| 47 | regulation of lipoprotein metabolic process (GO:0050746) | 3.28633326 |
| 48 | negative regulation of proteolysis (GO:0045861) | 3.22148608 |
| 49 | triglyceride catabolic process (GO:0019433) | 3.18068751 |
| 50 | macroautophagy (GO:0016236) | 3.16081960 |
| 51 | plasma membrane fusion (GO:0045026) | 3.15077719 |
| 52 | negative regulation of protein maturation (GO:1903318) | 3.10076798 |
| 53 | negative regulation of protein processing (GO:0010955) | 3.10076798 |
| 54 | defense response to bacterium (GO:0042742) | 3.05696658 |
| 55 | positive regulation of cell-cell adhesion (GO:0022409) | 3.00747859 |
| 56 | cysteine metabolic process (GO:0006534) | 3.00586602 |
| 57 | acylglycerol catabolic process (GO:0046464) | 2.98404833 |
| 58 | neutral lipid catabolic process (GO:0046461) | 2.98404833 |
| 59 | regulation of Cdc42 GTPase activity (GO:0043088) | 2.98093085 |
| 60 | L-serine transport (GO:0015825) | 2.97252601 |
| 61 | transepithelial transport (GO:0070633) | 2.93096220 |
| 62 | regulation of type 2 immune response (GO:0002828) | 2.85658255 |
| 63 | indole-containing compound metabolic process (GO:0042430) | 2.83795671 |
| 64 | negative regulation of hydrolase activity (GO:0051346) | 2.80159397 |
| 65 | positive regulation of cholesterol transport (GO:0032376) | 2.77875163 |
| 66 | positive regulation of sterol transport (GO:0032373) | 2.77875163 |
| 67 | Golgi transport vesicle coating (GO:0048200) | 2.76178648 |
| 68 | COPI coating of Golgi vesicle (GO:0048205) | 2.76178648 |
| 69 | ethanol oxidation (GO:0006069) | 2.70820886 |
| 70 | cellular sodium ion homeostasis (GO:0006883) | 2.68372236 |
| 71 | white fat cell differentiation (GO:0050872) | 2.65822792 |
| 72 | regulation of endopeptidase activity (GO:0052548) | 2.64703892 |
| 73 | response to nitrosative stress (GO:0051409) | 2.64423941 |
| 74 | response to bacterium (GO:0009617) | 2.62815637 |
| 75 | negative regulation of glycogen biosynthetic process (GO:0045719) | 2.62485773 |
| 76 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.62132684 |
| 77 | brown fat cell differentiation (GO:0050873) | 2.58681667 |
| 78 | high-density lipoprotein particle remodeling (GO:0034375) | 2.58146878 |
| 79 | negative regulation of endocytosis (GO:0045806) | 2.57667910 |
| 80 | regulation of antigen processing and presentation (GO:0002577) | 2.56114948 |
| 81 | serine transport (GO:0032329) | 2.55753707 |
| 82 | negative regulation of metanephros development (GO:0072217) | 2.53302928 |
| 83 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 2.52901903 |
| 84 | regulation of peptidase activity (GO:0052547) | 2.51800158 |
| 85 | N-acetylneuraminate metabolic process (GO:0006054) | 2.43296473 |
| 86 | glycerolipid catabolic process (GO:0046503) | 2.42535099 |
| 87 | cellular modified amino acid catabolic process (GO:0042219) | 2.42051277 |
| 88 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.41943618 |
| 89 | oxaloacetate metabolic process (GO:0006107) | 2.40558772 |
| 90 | regulation of complement activation (GO:0030449) | 2.39906024 |
| 91 | cytolysis (GO:0019835) | 2.39371740 |
| 92 | regulation of cholesterol transport (GO:0032374) | 2.33803703 |
| 93 | regulation of sterol transport (GO:0032371) | 2.33803703 |
| 94 | negative regulation of glycogen metabolic process (GO:0070874) | 2.32728172 |
| 95 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.31982533 |
| 96 | positive regulation of glomerulus development (GO:0090193) | 2.31084117 |
| 97 | nerve growth factor signaling pathway (GO:0038180) | 2.29508784 |
| 98 | seminiferous tubule development (GO:0072520) | 19.0539366 |
| 99 | regulation of T cell tolerance induction (GO:0002664) | 10.9864967 |
| 100 | production of molecular mediator involved in inflammatory response (GO:0002532) | 10.7705117 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GATA1_22025678_ChIP-Seq_K562_Human | 5.15699062 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.79661576 |
| 3 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 4.44718340 |
| 4 | AR_21572438_ChIP-Seq_LNCaP_Human | 3.41416968 |
| 5 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 3.29212544 |
| 6 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.10299260 |
| 7 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.91602405 |
| 8 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.90878221 |
| 9 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.41682336 |
| 10 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.37240884 |
| 11 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.36054950 |
| 12 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.31317645 |
| 13 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.28832429 |
| 14 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.20539478 |
| 15 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 2.09880407 |
| 16 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 2.08069166 |
| 17 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.79608039 |
| 18 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.76534815 |
| 19 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.75949081 |
| 20 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.70319022 |
| 21 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.69007871 |
| 22 | STAT1_17558387_ChIP-Seq_HELA_Human | 1.62930947 |
| 23 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.56025404 |
| 24 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.51418311 |
| 25 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.50588801 |
| 26 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.48579786 |
| 27 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.47594528 |
| 28 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 1.45671473 |
| 29 | GATA3_21867929_ChIP-Seq_TH1_Mouse | 1.44339653 |
| 30 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.43118678 |
| 31 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 1.43058575 |
| 32 | P68_20966046_ChIP-Seq_HELA_Human | 1.42235029 |
| 33 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.40672775 |
| 34 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.40344224 |
| 35 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.39139344 |
| 36 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.39054274 |
| 37 | MYC_19915707_ChIP-ChIP_AK7_Human | 1.38878722 |
| 38 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.35903469 |
| 39 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.35410720 |
| 40 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.35094259 |
| 41 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.35094259 |
| 42 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.33574471 |
| 43 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.29991031 |
| 44 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 1.23914497 |
| 45 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.21582133 |
| 46 | FLI1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.21309189 |
| 47 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.18446591 |
| 48 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.17603172 |
| 49 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.15230697 |
| 50 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.13571079 |
| 51 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13218222 |
| 52 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.12899623 |
| 53 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.12882631 |
| 54 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.11903176 |
| 55 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.09066116 |
| 56 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 1.08182046 |
| 57 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.04887445 |
| 58 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 1.04355325 |
| 59 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.04265971 |
| 60 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.04233496 |
| 61 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.03235678 |
| 62 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.02672093 |
| 63 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.99325728 |
| 64 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.99005769 |
| 65 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.97887891 |
| 66 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.97826967 |
| 67 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.97498256 |
| 68 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.97251768 |
| 69 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.96610185 |
| 70 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.96342308 |
| 71 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.95880587 |
| 72 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.94883865 |
| 73 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.94758344 |
| 74 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.93377613 |
| 75 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.92831956 |
| 76 | KDM2B_26808549_Chip-Seq_K562_Human | 0.92627358 |
| 77 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.91070322 |
| 78 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.89766239 |
| 79 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.88343541 |
| 80 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.88295166 |
| 81 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.86853703 |
| 82 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86003892 |
| 83 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.85575907 |
| 84 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.84936954 |
| 85 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.84714692 |
| 86 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.84398434 |
| 87 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.83851000 |
| 88 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.83706952 |
| 89 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.82884885 |
| 90 | GATA1_19941826_ChIP-Seq_K562_Human | 0.81340341 |
| 91 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.80748127 |
| 92 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.80313448 |
| 93 | KDM2B_26808549_Chip-Seq_REH_Human | 0.80108447 |
| 94 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.78882696 |
| 95 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.78684135 |
| 96 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.78584284 |
| 97 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.76883370 |
| 98 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.76817994 |
| 99 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.76755094 |
| 100 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.75479253 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 5.05198984 |
| 2 | MP0003195_calcinosis | 4.61644935 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 4.35495107 |
| 4 | MP0002254_reproductive_system_inflammat | 4.18747879 |
| 5 | MP0003303_peritoneal_inflammation | 4.01447477 |
| 6 | MP0004043_abnormal_pH_regulation | 3.70727434 |
| 7 | MP0010234_abnormal_vibrissa_follicle | 3.31574790 |
| 8 | MP0005670_abnormal_white_adipose | 2.58066151 |
| 9 | MP0005410_abnormal_fertilization | 2.51691472 |
| 10 | MP0000003_abnormal_adipose_tissue | 2.49834645 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.42065448 |
| 12 | MP0004130_abnormal_muscle_cell | 2.28596279 |
| 13 | MP0005375_adipose_tissue_phenotype | 2.25340711 |
| 14 | MP0003329_amyloid_beta_deposits | 2.16430783 |
| 15 | MP0004185_abnormal_adipocyte_glucose | 2.04348568 |
| 16 | MP0005666_abnormal_adipose_tissue | 2.02781914 |
| 17 | MP0005365_abnormal_bile_salt | 1.97935348 |
| 18 | MP0003300_gastrointestinal_ulcer | 1.93821553 |
| 19 | MP0005360_urolithiasis | 1.87327723 |
| 20 | MP0003705_abnormal_hypodermis_morpholog | 1.86363338 |
| 21 | MP0001501_abnormal_sleep_pattern | 1.80535770 |
| 22 | MP0002837_dystrophic_cardiac_calcinosis | 1.77285387 |
| 23 | MP0008438_abnormal_cutaneous_collagen | 1.74248578 |
| 24 | MP0003566_abnormal_cell_adhesion | 1.72534580 |
| 25 | MP0002168_other_aberrant_phenotype | 1.71619243 |
| 26 | MP0003191_abnormal_cellular_cholesterol | 1.60600639 |
| 27 | MP0001765_abnormal_ion_homeostasis | 1.59780698 |
| 28 | MP0000604_amyloidosis | 1.59565015 |
| 29 | MP0009643_abnormal_urine_homeostasis | 1.53150131 |
| 30 | MP0002118_abnormal_lipid_homeostasis | 1.51798458 |
| 31 | MP0003690_abnormal_glial_cell | 1.49820495 |
| 32 | MP0005275_abnormal_skin_tensile | 1.42390884 |
| 33 | MP0002876_abnormal_thyroid_physiology | 1.40249335 |
| 34 | MP0001756_abnormal_urination | 1.38720686 |
| 35 | MP0004885_abnormal_endolymph | 1.34390507 |
| 36 | MP0004858_abnormal_nervous_system | 1.32782686 |
| 37 | MP0005332_abnormal_amino_acid | 1.31279467 |
| 38 | MP0001853_heart_inflammation | 1.30636434 |
| 39 | MP0003806_abnormal_nucleotide_metabolis | 1.29841125 |
| 40 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.25369635 |
| 41 | MP0005085_abnormal_gallbladder_physiolo | 1.25280712 |
| 42 | MP0002796_impaired_skin_barrier | 1.19907890 |
| 43 | MP0005636_abnormal_mineral_homeostasis | 1.12739893 |
| 44 | MP0000534_abnormal_ureter_morphology | 1.10721525 |
| 45 | MP0002971_abnormal_brown_adipose | 1.10247070 |
| 46 | MP0009780_abnormal_chondrocyte_physiolo | 1.10041549 |
| 47 | MP0003075_altered_response_to | 1.07401558 |
| 48 | MP0005334_abnormal_fat_pad | 1.05750680 |
| 49 | MP0003252_abnormal_bile_duct | 1.03758994 |
| 50 | MP0000609_abnormal_liver_physiology | 1.01381756 |
| 51 | MP0001440_abnormal_grooming_behavior | 0.96541054 |
| 52 | MP0002136_abnormal_kidney_physiology | 0.96485627 |
| 53 | MP0000537_abnormal_urethra_morphology | 0.96380236 |
| 54 | MP0003879_abnormal_hair_cell | 0.94319618 |
| 55 | MP0002909_abnormal_adrenal_gland | 0.91134866 |
| 56 | MP0004272_abnormal_basement_membrane | 0.89322800 |
| 57 | MP0002138_abnormal_hepatobiliary_system | 0.89196048 |
| 58 | MP0005535_abnormal_body_temperature | 0.86349926 |
| 59 | MP0002896_abnormal_bone_mineralization | 0.86270456 |
| 60 | MP0008875_abnormal_xenobiotic_pharmacok | 0.86217415 |
| 61 | MP0002653_abnormal_ependyma_morphology | 0.84731843 |
| 62 | MP0009763_increased_sensitivity_to | 0.83059834 |
| 63 | MP0009115_abnormal_fat_cell | 0.82269580 |
| 64 | MP0003959_abnormal_lean_body | 0.81696504 |
| 65 | MP0000013_abnormal_adipose_tissue | 0.79236880 |
| 66 | MP0005319_abnormal_enzyme/_coenzyme | 0.78591741 |
| 67 | MP0005377_hearing/vestibular/ear_phenot | 0.76942460 |
| 68 | MP0003878_abnormal_ear_physiology | 0.76942460 |
| 69 | MP0001764_abnormal_homeostasis | 0.76864889 |
| 70 | MP0003698_abnormal_male_reproductive | 0.74016309 |
| 71 | MP0000751_myopathy | 0.73959661 |
| 72 | MP0001666_abnormal_nutrient_absorption | 0.72647678 |
| 73 | MP0004019_abnormal_vitamin_homeostasis | 0.72554084 |
| 74 | MP0003632_abnormal_nervous_system | 0.68966487 |
| 75 | MP0002970_abnormal_white_adipose | 0.68838271 |
| 76 | MP0002733_abnormal_thermal_nociception | 0.68811861 |
| 77 | MP0004264_abnormal_extraembryonic_tissu | 0.68212230 |
| 78 | MP0002089_abnormal_postnatal_growth/wei | 0.68137920 |
| 79 | MP0006138_congestive_heart_failure | 0.67475560 |
| 80 | MP0003656_abnormal_erythrocyte_physiolo | 0.66922845 |
| 81 | MP0004036_abnormal_muscle_relaxation | 0.66762776 |
| 82 | MP0000249_abnormal_blood_vessel | 0.65870839 |
| 83 | MP0002295_abnormal_pulmonary_circulatio | 0.64741339 |
| 84 | MP0009384_cardiac_valve_regurgitation | 0.63518960 |
| 85 | MP0004270_analgesia | 0.63066757 |
| 86 | MP0002933_joint_inflammation | 0.63020393 |
| 87 | MP0002078_abnormal_glucose_homeostasis | 0.62906302 |
| 88 | MP0003633_abnormal_nervous_system | 0.61155735 |
| 89 | MP0005164_abnormal_response_to | 0.60167033 |
| 90 | MP0004145_abnormal_muscle_electrophysio | 0.59783695 |
| 91 | MP0000920_abnormal_myelination | 0.59780424 |
| 92 | MP0001881_abnormal_mammary_gland | 0.59770542 |
| 93 | MP0008961_abnormal_basal_metabolism | 0.59230907 |
| 94 | MP0003045_fibrosis | 0.59070708 |
| 95 | MP0003631_nervous_system_phenotype | 0.59068706 |
| 96 | MP0004859_abnormal_synaptic_plasticity | 0.59050918 |
| 97 | MP0005083_abnormal_biliary_tract | 0.58650145 |
| 98 | MP0003186_abnormal_redox_activity | 0.58123288 |
| 99 | MP0003634_abnormal_glial_cell | 0.57171436 |
| 100 | MP0000747_muscle_weakness | 0.55906757 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Choroideremia (HP:0001139) | 7.06697007 |
| 2 | Complement deficiency (HP:0004431) | 6.12955864 |
| 3 | Abnormality of the fovea (HP:0000493) | 6.05379065 |
| 4 | Abnormal rod and cone electroretinograms (HP:0008323) | 5.36964356 |
| 5 | Facial shape deformation (HP:0011334) | 4.97466164 |
| 6 | Potter facies (HP:0002009) | 4.97466164 |
| 7 | Vacuolated lymphocytes (HP:0001922) | 4.94060686 |
| 8 | Vascular calcification (HP:0004934) | 4.68827960 |
| 9 | Myocardial infarction (HP:0001658) | 4.58075198 |
| 10 | Bony spicule pigmentary retinopathy (HP:0007737) | 4.57817650 |
| 11 | Abnormality of complement system (HP:0005339) | 4.41375557 |
| 12 | Cardiovascular calcification (HP:0011915) | 4.34615862 |
| 13 | Neurofibrillary tangles (HP:0002185) | 4.29719072 |
| 14 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.18527565 |
| 15 | Hypopigmentation of the fundus (HP:0007894) | 4.17287088 |
| 16 | Hypophosphatemic rickets (HP:0004912) | 4.11117367 |
| 17 | Cerebral inclusion bodies (HP:0100314) | 4.04890675 |
| 18 | Intention tremor (HP:0002080) | 3.63269053 |
| 19 | Infantile muscular hypotonia (HP:0008947) | 3.29389307 |
| 20 | Metaphyseal cupping (HP:0003021) | 3.19475268 |
| 21 | Action tremor (HP:0002345) | 3.11751883 |
| 22 | Hand muscle atrophy (HP:0009130) | 3.07777041 |
| 23 | Hyperglycinuria (HP:0003108) | 3.07222901 |
| 24 | Supranuclear gaze palsy (HP:0000605) | 2.95865230 |
| 25 | Neoplasm of the heart (HP:0100544) | 2.95766018 |
| 26 | Agitation (HP:0000713) | 2.95174688 |
| 27 | Hyperphosphatemia (HP:0002905) | 2.87186433 |
| 28 | Hemiplegia (HP:0002301) | 2.83489283 |
| 29 | Dysostosis multiplex (HP:0000943) | 2.80200330 |
| 30 | Malnutrition (HP:0004395) | 2.77671132 |
| 31 | Stridor (HP:0010307) | 2.70749722 |
| 32 | Upper limb amyotrophy (HP:0009129) | 2.66832989 |
| 33 | Distal upper limb amyotrophy (HP:0007149) | 2.66832989 |
| 34 | Acanthosis nigricans (HP:0000956) | 2.64495803 |
| 35 | Abnormality of glycine metabolism (HP:0010895) | 2.62243180 |
| 36 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.62243180 |
| 37 | Ketoacidosis (HP:0001993) | 2.60376516 |
| 38 | Oligomenorrhea (HP:0000876) | 2.59186230 |
| 39 | Polar cataract (HP:0010696) | 2.55421286 |
| 40 | Hyperglycinemia (HP:0002154) | 2.52515291 |
| 41 | Rickets (HP:0002748) | 2.51858083 |
| 42 | Hypertriglyceridemia (HP:0002155) | 2.44388230 |
| 43 | Facial diplegia (HP:0001349) | 2.43940742 |
| 44 | 11 pairs of ribs (HP:0000878) | 2.42403675 |
| 45 | Diaphragmatic weakness (HP:0009113) | 2.39383834 |
| 46 | Xanthomatosis (HP:0000991) | 2.34127133 |
| 47 | Hemorrhage of the eye (HP:0011885) | 2.30203811 |
| 48 | Tubulointerstitial fibrosis (HP:0005576) | 2.25502347 |
| 49 | Abnormal hemoglobin (HP:0011902) | 2.23983950 |
| 50 | Subcapsular cataract (HP:0000523) | 2.21591791 |
| 51 | Ketosis (HP:0001946) | 2.20496560 |
| 52 | Focal segmental glomerulosclerosis (HP:0000097) | 2.20482827 |
| 53 | Widely patent fontanelles and sutures (HP:0004492) | 2.19846093 |
| 54 | Skin nodule (HP:0200036) | 2.19839657 |
| 55 | Abnormality of purine metabolism (HP:0004352) | 2.16920977 |
| 56 | Deep venous thrombosis (HP:0002625) | 2.15008081 |
| 57 | Abnormality of macular pigmentation (HP:0008002) | 2.10865908 |
| 58 | Loss of speech (HP:0002371) | 2.09266967 |
| 59 | Restlessness (HP:0000711) | 2.09066527 |
| 60 | Osteomalacia (HP:0002749) | 2.08673768 |
| 61 | Missing ribs (HP:0000921) | 2.08417642 |
| 62 | Choreoathetosis (HP:0001266) | 2.06541515 |
| 63 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.05877803 |
| 64 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.05877803 |
| 65 | Ectopia lentis (HP:0001083) | 2.05664446 |
| 66 | Difficulty running (HP:0009046) | 2.04448323 |
| 67 | Systemic lupus erythematosus (HP:0002725) | 2.03807544 |
| 68 | Mucopolysacchariduria (HP:0008155) | 1.97680146 |
| 69 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.97680146 |
| 70 | Clumsiness (HP:0002312) | 1.96005586 |
| 71 | Abnormality of macrophages (HP:0004311) | 1.91464505 |
| 72 | Ankle clonus (HP:0011448) | 1.90144959 |
| 73 | Muscle fiber splitting (HP:0003555) | 1.84254854 |
| 74 | Glomerulosclerosis (HP:0000096) | 1.83296594 |
| 75 | Central scotoma (HP:0000603) | 1.82418221 |
| 76 | Thin bony cortex (HP:0002753) | 1.82237084 |
| 77 | Abnormality of the calcaneus (HP:0008364) | 1.78952233 |
| 78 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.78907738 |
| 79 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.78907738 |
| 80 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.78907738 |
| 81 | Hyporeflexia of lower limbs (HP:0002600) | 1.78750649 |
| 82 | Gout (HP:0001997) | 1.78568456 |
| 83 | Testicular atrophy (HP:0000029) | 1.77581698 |
| 84 | Pseudobulbar signs (HP:0002200) | 1.73710110 |
| 85 | Hyperammonemia (HP:0001987) | 1.73146028 |
| 86 | Progressive neurologic deterioration (HP:0002344) | 1.73036423 |
| 87 | Epidermoid cyst (HP:0200040) | 1.72569550 |
| 88 | Right ventricular cardiomyopathy (HP:0011663) | 1.72404121 |
| 89 | Hyperparathyroidism (HP:0000843) | 1.70876859 |
| 90 | Cardiomegaly (HP:0001640) | 1.69164577 |
| 91 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.69112669 |
| 92 | Abnormality of the lumbar spine (HP:0100712) | 1.68756353 |
| 93 | Back pain (HP:0003418) | 1.65705047 |
| 94 | Hypoventilation (HP:0002791) | 1.64471087 |
| 95 | Hypophosphatemia (HP:0002148) | 1.64368495 |
| 96 | Intrahepatic cholestasis (HP:0001406) | 1.62987279 |
| 97 | Mutism (HP:0002300) | 1.61614504 |
| 98 | Macular degeneration (HP:0000608) | 1.61523335 |
| 99 | Growth hormone excess (HP:0000845) | 1.61450538 |
| 100 | Proximal tubulopathy (HP:0000114) | 1.58947109 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SIK1 | 3.50148661 |
| 2 | ERN1 | 3.43698861 |
| 3 | LMTK2 | 3.36514769 |
| 4 | TRIB3 | 3.27047210 |
| 5 | TAOK3 | 3.00519092 |
| 6 | MST4 | 2.83821881 |
| 7 | PKN2 | 2.71185455 |
| 8 | WNK4 | 2.59374277 |
| 9 | EPHB1 | 2.35833329 |
| 10 | LRRK2 | 2.15219792 |
| 11 | PDGFRA | 2.01496298 |
| 12 | MYLK | 1.96044516 |
| 13 | FER | 1.84382933 |
| 14 | PRKD3 | 1.82064820 |
| 15 | FGFR2 | 1.74359047 |
| 16 | RIPK4 | 1.58461805 |
| 17 | FGFR4 | 1.54055826 |
| 18 | TTN | 1.47984292 |
| 19 | BCKDK | 1.43456968 |
| 20 | RET | 1.41265377 |
| 21 | FRK | 1.37187275 |
| 22 | MAP2K4 | 1.30097828 |
| 23 | PTK2 | 1.26822792 |
| 24 | PTK6 | 1.25185414 |
| 25 | PAK3 | 1.24767033 |
| 26 | STK39 | 1.23357818 |
| 27 | MAP3K2 | 1.19596071 |
| 28 | TNK2 | 1.16912915 |
| 29 | NTRK1 | 1.13759862 |
| 30 | PTK2B | 1.13467662 |
| 31 | RIPK1 | 1.10499289 |
| 32 | CAMK1G | 1.04927759 |
| 33 | WNK1 | 1.04749857 |
| 34 | CAMK1D | 1.04372659 |
| 35 | LATS1 | 1.01181036 |
| 36 | PRKCH | 1.00972495 |
| 37 | PAK2 | 1.00207548 |
| 38 | EPHB2 | 0.98376447 |
| 39 | FLT3 | 0.98039502 |
| 40 | DDR2 | 0.96647154 |
| 41 | BMX | 0.96620287 |
| 42 | TYRO3 | 0.96135759 |
| 43 | INSR | 0.91457250 |
| 44 | LATS2 | 0.89803504 |
| 45 | CDK19 | 0.89549547 |
| 46 | KSR2 | 0.88449997 |
| 47 | TESK1 | 0.86787129 |
| 48 | MAP3K6 | 0.86559959 |
| 49 | DMPK | 0.84740323 |
| 50 | PAK6 | 0.83677416 |
| 51 | INSRR | 0.83413244 |
| 52 | FGFR3 | 0.81236095 |
| 53 | PDK4 | 0.78785271 |
| 54 | PDK3 | 0.78785271 |
| 55 | STK38 | 0.77685904 |
| 56 | EEF2K | 0.76546451 |
| 57 | ICK | 0.76474977 |
| 58 | PHKG2 | 0.76085081 |
| 59 | PHKG1 | 0.76085081 |
| 60 | JAK2 | 0.76021787 |
| 61 | SIK2 | 0.74089555 |
| 62 | NTRK3 | 0.73712131 |
| 63 | MAP3K4 | 0.72392609 |
| 64 | MAP2K1 | 0.71943121 |
| 65 | STK10 | 0.70182583 |
| 66 | SCYL2 | 0.65768351 |
| 67 | PRKCZ | 0.65414392 |
| 68 | PAK4 | 0.64945989 |
| 69 | SRC | 0.64263425 |
| 70 | MET | 0.63490311 |
| 71 | EGFR | 0.62384635 |
| 72 | STK38L | 0.61489801 |
| 73 | PRKCG | 0.61472785 |
| 74 | IRAK2 | 0.60913445 |
| 75 | PDGFRB | 0.59123913 |
| 76 | CDK5 | 0.58594742 |
| 77 | IRAK3 | 0.58463629 |
| 78 | GSK3A | 0.58387423 |
| 79 | MAP3K7 | 0.58374459 |
| 80 | FYN | 0.57563796 |
| 81 | AKT3 | 0.55380666 |
| 82 | ILK | 0.54745629 |
| 83 | MAP3K12 | 0.54359519 |
| 84 | ERBB2 | 0.53633217 |
| 85 | PRKD1 | 0.53260448 |
| 86 | EPHA2 | 0.52746533 |
| 87 | FGFR1 | 0.50934588 |
| 88 | PRKACG | 0.50380887 |
| 89 | MST1R | 0.48845202 |
| 90 | GRK6 | 0.48767114 |
| 91 | PDK2 | 0.47716201 |
| 92 | GRK5 | 0.46361436 |
| 93 | CDK6 | 0.46128556 |
| 94 | ALK | 0.44635584 |
| 95 | DAPK2 | 0.44155437 |
| 96 | JAK1 | 0.42800548 |
| 97 | PDK1 | 0.42010992 |
| 98 | PDPK1 | 0.41643924 |
| 99 | CSNK1E | 0.41162057 |
| 100 | MINK1 | 0.39213633 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.43998368 |
| 2 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.59793266 |
| 3 | Glutathione metabolism_Homo sapiens_hsa00480 | 3.40622516 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.00814929 |
| 5 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 2.77013238 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.74239187 |
| 7 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.72808862 |
| 8 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.55008685 |
| 9 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.37342860 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.33512204 |
| 11 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.28453304 |
| 12 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.27113192 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.98098159 |
| 14 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.92823413 |
| 15 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.74878301 |
| 16 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.74494800 |
| 17 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.71232960 |
| 18 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.55546647 |
| 19 | ABC transporters_Homo sapiens_hsa02010 | 1.50145469 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.46566699 |
| 21 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.46523672 |
| 22 | Salivary secretion_Homo sapiens_hsa04970 | 1.45066323 |
| 23 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.36945819 |
| 24 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.36186603 |
| 25 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.30553339 |
| 26 | Lysosome_Homo sapiens_hsa04142 | 1.29345697 |
| 27 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.27239866 |
| 28 | Other glycan degradation_Homo sapiens_hsa00511 | 1.25577788 |
| 29 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.24820524 |
| 30 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.21824228 |
| 31 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.20979440 |
| 32 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.15133107 |
| 33 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.14667148 |
| 34 | Renin secretion_Homo sapiens_hsa04924 | 1.05393172 |
| 35 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.03386524 |
| 36 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.02663840 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.02590435 |
| 38 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.02578463 |
| 39 | Prion diseases_Homo sapiens_hsa05020 | 0.98482200 |
| 40 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.95177538 |
| 41 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.95121207 |
| 42 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.90162564 |
| 43 | Carbon metabolism_Homo sapiens_hsa01200 | 0.89683039 |
| 44 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.87344892 |
| 45 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.84862784 |
| 46 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.84551194 |
| 47 | Bile secretion_Homo sapiens_hsa04976 | 0.82593798 |
| 48 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.81925819 |
| 49 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.75175201 |
| 50 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.73398117 |
| 51 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.73151540 |
| 52 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.71409834 |
| 53 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.68685755 |
| 54 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.68549766 |
| 55 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.66479202 |
| 56 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.66042118 |
| 57 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.65674473 |
| 58 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.65139430 |
| 59 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.64453377 |
| 60 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.63802470 |
| 61 | Peroxisome_Homo sapiens_hsa04146 | 0.63801995 |
| 62 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.61195550 |
| 63 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.54938018 |
| 64 | GABAergic synapse_Homo sapiens_hsa04727 | 0.54866984 |
| 65 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.50564904 |
| 66 | Long-term potentiation_Homo sapiens_hsa04720 | 0.49532629 |
| 67 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.48533387 |
| 68 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.48251189 |
| 69 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.45551219 |
| 70 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.45438228 |
| 71 | Circadian entrainment_Homo sapiens_hsa04713 | 0.44120183 |
| 72 | Histidine metabolism_Homo sapiens_hsa00340 | 0.42232792 |
| 73 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.42098685 |
| 74 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.40648588 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.38170333 |
| 76 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.37090830 |
| 77 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.36578761 |
| 78 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.35468144 |
| 79 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.34531008 |
| 80 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.34509321 |
| 81 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.34220648 |
| 82 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.33023350 |
| 83 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.31690374 |
| 84 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.31324230 |
| 85 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.31309981 |
| 86 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.29773525 |
| 87 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.28847585 |
| 88 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.26861805 |
| 89 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.25892503 |
| 90 | Insulin secretion_Homo sapiens_hsa04911 | 0.24923353 |
| 91 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.21620364 |
| 92 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.21605367 |
| 93 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.21133544 |
| 94 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.21033103 |
| 95 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.20879465 |
| 96 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.20001440 |
| 97 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.19996431 |
| 98 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.18988557 |
| 99 | Melanogenesis_Homo sapiens_hsa04916 | 0.18934507 |
| 100 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.17888927 |

